Blood

923 papers64 directions
Blood is a long-standing publication venue for hematological research, with active contributions in the corpus spanning from 1973 through 2026. In the context of machine learning and artificial intelligence, the venue focuses on the integration of computational methods with clinical hematology to improve patient outcomes. Its content frequently addresses the development of independent biomarkers for disease prognosis, risk stratification for precision treatment selection, and the identification of molecular regulatory axes to overcome chemotherapy resistance. The venue publishes research on the application of AI-based diagnostic tools, such as those used for identifying myelodysplastic syndromes, and the use of integrated profiling to predict treatment responses in conditions like acute myeloid leukemia. Recent papers also explore technical frameworks for data science in medicine, including the generation of synthetic data over federated learning systems to accelerate personalized medicine. This research often utilizes large-scale data sources, such as nationwide electronic health record databases, to conduct epidemiological studies on conditions like venous thromboembolism. In the broader research community, Blood serves as a platform for addressing the statistical and methodological challenges of applying data science to specialized medicine. This includes investigating the generalizability gap in single-center clinical research and managing statistical power challenges in rare disease studies. Prolific contributors such as Zhixiang Shen, Aaron D. Schimmer, and Véronique Voisin highlight the venue's role in bridging bridging strategies for stem cell transplantation with advanced predictive modeling and microvascular visualization techniques.

Papers by Year

2026 4
2025 99
2024 129
2023 83
2022 72
2021 31
2020 44
2019 40
2018 42
2017 17
2016 30
2015 30
2014 26
2013 30
2012 33
2011 32
2010 24
2009 31
2008 25
2007 13
2006 17
2005 22
2004 15
2003 6
2002 4
2001 8
2000 1
1999 2
1998 2
1997 4
1996 1
1995 1
1993 1
1990 4
1988 1
1987 1
1974 1
1973 1

Top Research Directions

Research directions most represented by papers from this venue.

Viscoelastic Monitoring of Whole Blood Coagulation 2
The Non-Additive Toxicity of Multi-Modal Adjunctive Therapies 2
Targeting the Mechanisms of Cancer Stem Cell Resistance 2
Overcoming Data Scarcity in Rare Disease Research 2
Transcriptional Artifacts and Selective Loss from Tissue Dissociation 1
Quantifying Clinical Relevance Beyond Statistical Significance 1
Molecular Clonal Tracking via Immune Repertoire Sequencing 1
Discovering Driver Pathways via Mutational Mutual Exclusivity 1
The Structural Convergence of Adaptive Immune Repertoires 1
Predicting Therapeutic Efficacy Before Morphological Change 1
Synergistic Innate Immune Activation via Combinatorial Adjuvants 1
Genetic Lineage Tracing for Mapping Cellular Ancestry 1
Mechanisms of Metabolic Drug-Drug Interactions 1
Bioorthogonal Labeling and Chemical Proteomics for Target Identification 1
The Dynamics of Dose Dependent Therapeutic Efficacy 1

Top Authors

AuthorPapers
Zhixiang Shen38
Jane E. Barker19
Hongyu An15
Barbara D. Lam12
Zinaida Good12
Mikel Hernaez11
Bita Sahaf9
Lori Muffly9
Matthew J. Frank9
James Nichols8
Jorge J. Nieva8
Allon M Klein7
Filippo Utro6
Jianqiang Li6
Kahn Rhrissorrakrai6
Meong Hi Son6
Moksha H. Desai6
Saurabh Dahiya6
Zachary Ehlinger6
Andrew R. Rezvani5

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Coagulopathy In Trauma Patients Is Accompanied By Oxidation Of a Methionine Residue In The αC Domain Of Fibrinogen and Abnormal Fibrin Polymerization2013
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients2013
Distinct Roles Of PD-1 Itsm and ITIM In Regulating Interactions With SHP-2, ZAP-70 and Lck, and PD-1-Mediated Inhibitory Function2013
Effects Of Dalteparin On The Heparanase/Syndecan-1 Axis In a Randomized Phase 2 Clinical Trial Of Patients With Treatment-Naive Multiple Myeloma2013
Five years’ Follow-Up Study For Frequency Of Monoclonal Gammopathy Of Undetermined Significance (MGUS) In a Korean Elderly Urban Cohort2013
Free Circulating Epstein Barr Virus DNA Load In Indian Children With Hodgkin Lymphoma As a Biomarker Of EBV-Associated Disease2013
Frontline Nilotinib Results In Superior Rates Of Molecular Response Versus Imatinib In Chinese Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): ENESTchina 12-Month Primary Analysis2013
Hemaexplorer 2.0: A Free Access Internet Platform For Visualization Of Gene Expression In AML Patients and The Normal Hematopoietic Hierarchy2013
Hematopoietic Stem Cell Gene Therapy For Wiskott- Aldrich Syndrome2013
High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology2013
Homozygous hemoglobin C disease2013
Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions2013
Improving The Analysis Of Gene Expression Profiles By Comparing AML Blasts With Their Nearest Normal Counterparts2013
JAK Inhibition Reduces CD25 high CD27+ FOXp3+ T Regulatory Cells and Causes a Silencing Of T Effector Cells In Patients With Myeloproliferative Neoplasms Whilst Promoting a TH17 Phenotype2013
Mir-126 Governs Human Leukemia Stem Cell Quiescence and Chemotherapy Resistance2013
Myeloid Derived Suppressor Cell Expansion Correlates With Increased regulatory T Cells In Myelodysplastic Syndrome2013
PD-1 Induces Metabolic Reprogramming Of Activated T Cells From Glycolysis To Lipid Oxidation2013
Pomalidomide In MPN–associated Myelofibrosis With Cytopenia: Results Of The Mpnsg 01-09 Study2013
SF3B1 Mutant Clones From Patients With Refractory Anaemia With Ringed Sideroblasts (RARS) Originate From The Early Haematopoietic Stem Cells and Maintain Their Engraftment Potential2013
Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia2013
Targeted Therapy Of Acute Myeloid Leukemia By A CD117-Specific Aptamer-Drug-Conjugate2013
The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse2013
Topical Sodium Nitrite Is Effective In Reducing Leg Ulcer-Associated Pain In Patients With Sickle Cell Disease2013
Aldehyde Dehydrogenase 3a2 (Aldh3a2) Represents a Distinct Metabolic Vulnerability in MLL-AF9 AML Leukemia Initiating Cells2012
Amino Acid Balance with Extended Daily Diafiltration in Acute Kidney Injury2012
Analysis of β3 Binding to the c-Src SH3 Domain2012
Annual Congress of the Chinese Blood Purification Center Administration Committee2012
Biochemical Effects of Phosphate-Containing Replacement Fluid for Continuous Venovenous Hemofiltration2012
Bortezomib-Based Induction Therapy Followed by High-Dose Chemotherapy and Autologous Stem Cell transplantation in Newly-Diagnosed Myeloma: Initial Report From a Chinese Multiple-Center Study2012
Bosutinib As Therapy for Chronic Phase Chronic Myeloid Leukemia Following Resistance or Intolerance to Imatinib: 36-Month Minimum Follow-up Update2012
Chronic Inhibition of Mitochondrial Translation Alters Metabolism and Stemness in AML2012
Clinical and prognostic role of annexin A2 in multiple myeloma2012
Contents Vol. 33,20122012
CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia2012
Decitabine, low-dose cytarabine and aclarubicin combination with granulocyte colony-stimulating factor priming for the induction chemotherapy of older patients with myelodysplastic syndromes and acute2012
Expansion of CD141int Dendritic Cells in Myelodysplastic Syndrome (MDS)2012
FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation2012
First-Line Treatment and Management of Chronic Myeloid Leukemia (CML) in Clinical Practice: Update of > 1800 Patients (Pts) in the WORLD CML Registry2012
Frequency and Clinical Presentation of Polycomb Repressive Complex 2 (PRC2) Component Mutations in Childhood Acute Lymphoblastic Leukemia2012
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis2012
Homoharringtonine-Based Induction Regimens for Patients with De Novo Acute Myeloid Leukemia: A Multicenter Randomized Controlled Phase 3 Trial2012
Inflammation, Obesity, and Thrombosis2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation2012
Iterative Germinal Center Re-Entries of Memory B-Cells with t(14;18) Translocation and Early Steps of Follicular Lymphoma Progression2012
Kruppel-Like Factor, Klf9, Promotes Proliferation of Notch-Independent Precursor T-Cell Lymphoblastic Lymphomas2012
Myelodyspastic syndrome with complex cytogenetics2012
Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.2012
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia2012
PD-1 Couples Glucose Starvation with Autophagy and Survival Through AMPK-Mediated Phosphorylation of Ulk12012
Pomalidomide in Myelofibrosis with Cytopenia: First Results of the Mpnsg 01–09 Study (ClinicalTrials.gov Identifier: NCT00949364).2012

« prev Page 14/19 next »